+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 85Years
FEMALE
ID06932302

At-Home Electrical Nerve Stimulation and Smart Vibrator Treatment for Female Sexual Dysfunction in Women Aged 18 to 85

Led by University of Michigan · Updated on 2025-12-23

24

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of non-invasive dorsal genital nerve stimulation DGS for treating female sexual dysfunction FSD in premenopausal and postmenopausal women. This pilot study aims to see if women with FSD can follow an at-home treatment plan and if DGS can improve symptoms related to sexual arousal. Some participants will also use a smart vibrator to compare results. Participants will be randomly assigned to one of three groups DGS only, DGS combined with a smart vibrator, or smart vibrator only. The DGS treatment uses a device called the UCon system with patch electrodes to deliver electrical stimulation to the dorsal genital nerve. The smart vibrator records physiological responses during use and is used twice a week at home. Participants will attend sessions at Michigan Medicine at the beginning and end of the study. Researchers will track how many DGS sessions are completed and monitor any related adverse events over about nine weeks. They will also measure changes in sexual function using the Female Sexual Function Index and assess overall patient impressions of change. The study lasts roughly three weeks for initial measurements with follow-up through week nine.

CONDITIONS

Brief Title

At-Home Neuromodulation for Female Sexual Dysfunction

Research Team

Y

Yike Liu

T

Tim Bruns, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here